Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease

Not Applicable

• Conditions: inflammatory bowel disease; Crohn's disease; ulcerative colitis; indeterminate colitis; COVID-19; Oral and Gastrointestinal - Crohn's disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Mental Health - Anxiety; Oral and Gastrointestinal - Inflammatory bowel disease; Mental Health - Depression

• Registration Number: ACTRN12620000448943
• Lead Sponsor: Deakin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-06
• Study Completion: 2021-09-08
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

Diagnosis of IBD: Crohn’s disease, ulcerative colitis or indeterminate colitis established using standard criteria (we will ask for the details of patient's gastroenterologist, and these will be verified by our team);
Distress: at least mild distress on K10 (scores 20-29);
Age: 18 years and older;
Other: able to read and write in English, with access to internet/telephone to participate in online/telephone intervention and available to participate for approx. 30 minutes for 4 consecutive days (likely in the evening).

Exclusion Criteria

Severe distress based on K10 (scores 30-50 very high distress) as these participants would require a more intensive therapeutic approach.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Distress measured on Kessler Psychological Distress Scale (K10)[Baseline, post-intervention (within one week since the completion of the intervention, primary endpoint), 3 months post-intervention]